Google hopes to use artificial intelligence to turn your phone into a “doctor in your pocket.”
Prior to gaining the support of the Biden administration and skeptic lawmakers, the tech giant must persuade them that its health AI poses no threat to smaller rivals or patient privacy and safety.
Just as regulators are beginning to draft regulations governing AI, Google has put together a strong lobbying team to exert influence. Congressmen, however, express concern that the business is utilizing its cutting-edge AI in healthcare before the government has had a chance to set regulations. Google’s rivals fear the company is attempting to corner the market. Given Google’s track record of snatching up personal information, both are concerned about what might happen to patient privacy.
“There is great promise in many of these tools to save more lives,” said Sen. Mark Warner (D-Va.), adding that “they also have the potential to do exactly the opposite — harm patients and their data, reinforce human bias, and add burdens to providers as they navigate a clinical and legal landscape without clear norms.”
Google’s artificial intelligence scours clinical records, research papers, imaging, and clinical rules to assist specialists with diagnosing sicknesses and assess therapy choices. These tools are already being sold to hospitals by the tech giant. It’s inked an arrangement with the Mayo Center, for one — and it predicts considerably more, including direct-to-purchaser applications.
Warner as of late sent a letter to research Chief Sundar Pichai, saying he was pained that clinics are utilizing the organization’s computer based intelligence without adequate verifying.
Mark Isakowitz, former Ohio GOP Sen. Rob Portman’s chief of staff and Google’s North American head of policy and government affairs, responded that the company’s technology is not trained on personal health information and is only used in a limited capacity. Health systems, according to Isakowitz, have control over how it is used and monitor its behavior.